Dr. Mitchel L. Fromm
Claim this profileCleveland Clinic Akron General
Studies Lung Cancer
Studies Small Cell Lung Cancer
5 reported clinical trials
13 drugs studied
Area of expertise
1Lung Cancer
Stage IV
2Small Cell Lung Cancer
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Mitchel L. Fromm is currently running
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
MRI Monitoring vs. Preventive Brain Radiation
for Small Cell Lung Cancer
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria
More about Mitchel L. Fromm
Clinical Trial Related8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mitchel L. Fromm has experience with
- Docetaxel
- Gemcitabine
- Erlotinib Hydrochloride
- Local Consolidation Therapy
- Pemetrexed Disodium
- Prophylactic Cranial Irradiation
Breakdown of trials Mitchel L. Fromm has run
Lung Cancer
Small Cell Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Small Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitchel L. Fromm specialize in?
Mitchel L. Fromm focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Mitchel L. Fromm currently recruiting for clinical trials?
Yes, Mitchel L. Fromm is currently recruiting for 2 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mitchel L. Fromm has studied deeply?
Yes, Mitchel L. Fromm has studied treatments such as Docetaxel, Gemcitabine, Erlotinib Hydrochloride.
What is the best way to schedule an appointment with Mitchel L. Fromm?
Apply for one of the trials that Mitchel L. Fromm is conducting.
What is the office address of Mitchel L. Fromm?
The office of Mitchel L. Fromm is located at: Cleveland Clinic Akron General, Akron, Ohio 44307 United States. This is the address for their practice at the Cleveland Clinic Akron General.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.